New Bidentate Phosphorus Ligands Based on a Norbornane Backbone for Rhodium-Catalyzed Asymmetric Hydrogenation

Abstract

A new class of bidentate diphosphite and diphosphinite ligands has been developed from inexpensive norbornadiene. These ligands exhibited excellent enantioselectivities in the Rh(I)-catalyzed asymmetric hydrogenation of olefin derivatives (up to 99.9% ee).

asymmetric hydrogenation - bidentate phosphorus ligands - diphosphite ligands - diphosphinite ligand - rhodium

References and Notes

1a Reetz MT. Neugebauer T. Angew. Chem. Int. Ed.  1999,  38:  179 

1b Reetz MT. Mehler G. Angew.Chem. Int. Ed.  2000,  39:  3889 

1c Chan ASC. Hu WH. Pai CC. Lau CP. J. Am. Chem. Soc.  1997,  119:  9570 

1d Zhu GX. Zhang XM. J. Org. Chem.  1998,  63:  3133 

1e Diéguez M. Ruiz A. Claver C. J. Org. Chem.  2000,  67:  3796 

2a Diéguez M. Pàmies O. Ruiz A. Castillón S. Claver C. Chem. Eur. J.  2001,  7:  3086 

2b Diéguez M. Pàmies O. Claver C. Tetrahedron: Asymmetry  2004,  15:  2113 

3a Landis CR. Hilfenhaus P. Feldgus S. J. Am. Chem. Soc.  1999,  121:  8741 

3b Feldgus S. Landis CR. J. Am. Chem. Soc.  2000,  122:  2714 

3c Landis CR. Feldgus S. Angew. Chem. Int. Ed.  2000,  39:  2863 

3d Feldgus S. Landis CR. Organometallics  2001,  20:  2374 

4a Jia X. Li X. Xu L. Shi Q. Yao X. Chan ASC.
J. Org. Chem.  2003,  68:  4539 

4b Zeng QL. Liu H. Cui X. Mi AQ. Jiang YZ. Li XS. Chio MCK. Chan ASC. Tetrahedron: Asymmetry  2002,  13:  115 

4c Jia X. Guo R. Li X. Yao X. Chan ASC. Tetrahedron Lett.  2002,  43:  5541 

5 Reetz MT. Meiswinkel A. Mehler G. Angermund K. Graf M. Thiel W. Mynott R. Blackmond DG. J. Am. Chem. Soc.  2005,  127:  10305 

6a Hu AG. Fu Y. Xie JH. Zhou H. Wang LX. Zhou QL. Angew. Chem. Int. Ed.  2002,  41:  2348 

6b Fu Y. Guo XX. Zhu SF. Hu AG. Xie JH. Zhou QL. J. Org. Chem.  2004,  69:  4648 

6c Liu Y. Ding KL. J. Am. Chem. Soc.  2005,  127:  10488 

6d Zhao BG. Wang Z. Ding KL. Adv. Synth. Catal.  2006,  348:  1049 

6e Liu Y. Sandoval CA. Yamaguchi Y. Zhang X. Wang Z. Kato K. Ding KL. J. Am. Chem. Soc.  2006,  128:  14212 

7 Reetz MT. Goossen LJ. Meiswinkel A. Paetzold J. Jensen JF. Org. Lett.  2003,  5:  3099 

8 Bernsmann H. van den Berg M. Hoen R. Minnaard AJ. Mehler G. Reetz MT. De Vries JG. Feringa BL. J. Org. Chem.  2005,  70:  943 

9 Zhang XM. Enantiomer  1999,  4:  451 

10 Reetz MT. Li XG. J. Am. Chem. Soc.  2006,  128:  1044 

11 Hayashi T. Ueyama K. Tokunaga N. Yoshida K. J. Am. Chem. Soc.  2003,  125:  11508 

12 Berkessel A. Schröder M. Sklorz CA. Tabanella S. Vogl N. Lex J. Neudörfl JM. J. Org. Chem.  2004,  69:  3050 

13 Berkessel A. Menche D. Sklorz CA. Schröder M. Paterson I. Angew. Chem. Int. Ed.  2003,  42:  1032 

14 Vandyck K. Matthys B. Willen M. Robeyns K. Van Meervelt L. Van der Eycken JV. Org. Lett.  2006,  8:  363 

15a Uozumi Y. Lee SY. Hayashi T. Tetrahedron Lett.  1992,  33:  7185 

15b Weissfloch A. Azerad R. Bioorg. Med. Chem.  1994,  2:  493 

16 Cai CL. Xia CG. Synthesis  2006,  2297 

17

Ligands Preparation (Scheme 1)
The Preparation of Ligand 3
A 10 mL Schlenk flask was charged with diol 2 (100 mg, 0.78 mmol), DMAP (20 mg), Et₃N (160 mg, 1.6 mmol) and THF (5 mL) under nitrogen. The mixture was stirred at 0 °C. A solution of chlorodiphenylphosphine (0.3 mL, 1.56 mmol) in THF (2 mL) was added dropwise with stirring, then stirred at r.t. for 24 h. After filtration, the solvent was removed under vacuum. The crude product was purified through flash chromatography to give pure product as a thick liquid; yield 233 mg (47%). MS (EI): m/z = 496 [M⁺]. ¹H NMR (400 MHz, CDCl₃): δ =7.44-7.13 (m, 20 H, Ph), 4.70-4.69 (b, 2 H, C2 and C5), 2.25 (s, 2 H, bridgehead), 1.92 (d, 2 H, endo of C3 and C5), 1.69 (m, 2 H, exo of C3 and C5), 1.23 (s, 2 H, bridge). ¹³C NMR (100 MHz, CDCl₃): δ = 149.678-122.009 (Ph), 75.628 (O-C), 42.500(bridgehead), 34.849 (bridge), 28.965 (C3 and C5). ³¹P NMR (162 MHz, CDCl₃): δ = 109.130.
Preparation of Ligand 4a
Under nitrogen, the freshly prepared chlorophosphoric acid ester (1.56 mmol) from 2,2-dihydroxy-1,1-biphenyl was dissolved in THF (6 mL) and cooled to -30 °C. Then, Et₃N (3.12 mmol) and DMAP (10 mg) in THF (1 mL) was added dropwise and the reaction was stirred for 30 min. Afterwards, diol 2 (100 mg, 0.78 mmol) in THF (3mL) was added dropwise at -30 °C and the mixture was allowed to warm to r.t. and stirred for 24 h. The mixture was filtrated and the filtrate was then passed through a short alumina column (d = 0.5 cm, L = 3 cm) to give the corresponding product as a white solid; 390 mg (90%). ¹H NMR (400 MHz, CDCl₃): δ = 7.52-7.23 (m,16 H, Ph), 4.42-4.37 (b, 2 H, C2 and C5), 2.31 (s, 2 H, bridgehead), 2.01-1.98 (d, 2 H, endo of C3 and C5), 1.77-1.70 (m, 2 H, exo of C3 and C5), 1.36 (s, 2 H, bridge). ¹³C NMR (100 MHz, CDCl₃): δ = 142.603-128.159 (Ph), 80.685 (C2 and C5), 42.303 (bridgehead), 35.365 (bridge), 29.268 (C3 and C5). ³¹P NMR (162 MHz, CDCl₃): δ = 145.473. ESI-HRMS: m/z calcd for C₃₁H₂₆O₆P₂ [M + K]: 595.0836; found: 595.0846.
Preparation of Ligand 4b Same procedure as for preparation of 4a; yield 78%. ¹H NMR (400 MHz, CDCl₃): δ = 7.96-7.22 (m, 24 H, BINOL), 4.59 (b, 2 H, C2 and C5), 2.25 (s, 2 H, bridgehead), 1.93-1.897 (d, 2 H, endo of C3 and C5), 1.77-1.72 (m, 2H, exo of C3 and C5), 1.24 (s, 2 H, bridge). ¹³C NMR (100 MHz, CDCl₃): δ = 148.556-121.919 (BINOL), 76.02 (C2 and C5), 42.348 (bridgehead), 34.599 (bridge), 28.988 (C3 and C5). ³¹P NMR (162 MHz, CDCl₃): δ = 141.967. ESI-HRMS: m/z calcd for C₄₇H₃₄O₆P₂ [M + Na]: 779.1723; found: 779.1734.
Preparation of Ligand 4c
Same procedure as for preparation of 4a; yield 81%. ¹H NMR (400 MHz, CDCl₃): δ = 7.89-7.16 (m, 24 H, BINOL), 4.48 (b, 2 H, C2 and C5), 2.15 (s, 2 H, bridgehead), 1.87-1.84 (d, 2 H, endo of C3 and C5), 1.58-1.1.53 (m, 2 H, exo of C3 and C5), 1.03 (s, 2 H, bridge). ¹³C NMR (100 MHz, CDCl₃): δ = 148.556-121.919 (BINOL), 75.825 (C2 and C5), 42.454 (bridgehead), 34.955 (bridge), 28.927 (C3 and C5). ³¹P NMR (162 MHz, CDCl₃): δ = 139.921. ESI-HRMS: m/z calcd for C₄₇H₃₄O₆P₂ [M + K]: 795.1462; found: 795.1461.